secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001437749-23-012106
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q1 sales up 22% organic to $47.1M; EPS flat at $0.27; issues guidance
------------------------------------------------------------------------------

- Sales $47.1M, +19% (+22% organic); net income $6.0M flat; diluted EPS $0.27 (-1%).
- Valvulotomes (+29%), carotid patches (+17%), bovine grafts (+22%), allografts (+42%), carotid shunts (+18%) led record Q1 sales.
- Q2 2023 guidance: sales $47.1M–$49.5M; EPS $0.30–$0.35. Full year: sales $187.1M–$193.1M; EPS $1.14–$1.27.
- Quarterly dividend $0.14/share, payable June 1, 2023 to holders of record May 17, 2023.
- Agreed to distribute Aziyo porcine cardiac patches in US for three years (option to acquire); Aziyo's 2022 US patch sales $6.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774923012106/0001437749-23-012106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774923012106/lmat20230502_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-012106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer